Addressing The Unmet Need of Ocular Pain
EyeCool Therapeutics is committed to delivering fast, lasting relief for patients suffering from Chronic Ocular Surface Pain (COSP)
Our Focus
COSP is a newly defined, often misdiagnosed condition marked by persistent eye pain, burning, dryness, and discomfort—even when no clinical signs are visible. First described as a distinct disease state by Galor et al. in 2022, COSP has been shown to be as disabling as fibromyalgia or migraine, yet no FDA-approved treatments exist.1